Philippines: FDA Circular 2025-007 | Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) January 20, 2026
Philippines: Further Extension of the Suspension Period Under Department Circular No. 2025-0240 and Its Subsequent Extension, Pertaining to the Implementation of Administrative Order No. 2024-0016 Entitled, “Implementation Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration” January 20, 2026
Philippines: FDA Circular No. 2025-006 on Online User Account Registration and Renewal January 12, 2026
Philippines: Draft for Comments – Operational Procedures on the Application for Sales Promotion Permit January 6, 2026
Philippines: Administrative Order No. 2025-0024 – Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use December 24, 2025
Philippines: Rescission of Administrative Order on Essential Medical Devices Framework October 6, 2025
Philippines: Guidelines for the Disposal of Forfeited Radio Communications Equipment September 30, 2025
Philippines: DOH Extends Suspension of FDA’s New Fees and Charges Under AO No. 2024-0016 September 11, 2025
Philippines: FDA Advisory No. 2025-0095-A || Lifting of the Advisory on the Interim Extension of Renewal Application Period of LTO Prior to Expiration of Validity Under FDA Advisory No. 2025-0095 July 8, 2025
Philippines: FDA Advisory No. 2025-0729 || Guidelines on the Re-issuance of Order of Payment July 8, 2025
Philippines: DOH Advisory Re: Temporary 60-Working Day Suspension of AO 2024-0016 on New FDA Fees and Charges June 13, 2025
Philippines: Department of Health approves the recommendation of Food and Drug Administration to temporarily suspend New Regulatory Fees. June 2, 2025
Philippines: Draft for Comments || Guidelines on the Recall of Authorized Health Products Regulated by the Food and Drug Administration April 7, 2025
